Transglutaminase 3 IgG

If you have a chronic, intensely itchy rash with small blisters and your standard celiac blood tests came back normal, this is one of the few markers that looks in a different direction. It reflects an immune reaction aimed at your skin, not just your gut.

This is a research-grade test, not a routine screen. It is most useful as a supporting clue in gluten-related disease, especially the skin condition dermatitis herpetiformis, and it is best read alongside other tests rather than on its own.

What This Antibody Actually Measures

The test measures the amount of TG3 (transglutaminase 3) IgG, an antibody your immune system produces against transglutaminase 3, a protein made by skin cells in the upper layers of your skin. High levels reflect an immune system that has begun reacting to this skin protein. The test does not measure the protein itself or any damage directly.

In gluten-related disease, this antibody response is thought to begin in the gut and show up in the skin. One point matters for interpretation: the diagnostic hallmark of dermatitis herpetiformis is a different antibody class (IgA) deposited in the skin, while this blood test measures the IgG class. The two are related but not interchangeable, and most of the strongest evidence in this area comes from IgA measurements.

The Blistering Rash of Gluten Sensitivity

Dermatitis herpetiformis is the skin form of gluten sensitivity, and transglutaminase 3 is considered its primary target. In one study of people with this rash, antibodies against the skin enzyme were found in about 95% (36 of 38) of untreated patients, compared with about 79% (30 of 38) for the standard celiac antibody, which targets transglutaminase 2. That 95% came from a small study; a larger multicenter study reported a lower sensitivity of about 73%, so the real-world figure may be more modest. These skin-disease studies largely measured the IgA class rather than the IgG class this test reports.

What this means for you: if you have an unexplained itchy, blistering rash, transglutaminase 3 antibodies can add weight to a suspicion of gluten-driven skin disease. But the most specific test remains a skin biopsy of skin next to the rash, examined under a special stain (called direct immunofluorescence), not a blood test.

When Standard Celiac Tests Come Back Negative

Among gluten-sensitive patients with confirmed gut damage whose standard celiac antibody (against transglutaminase 2) was negative, testing for antibodies to other transglutaminase family members (transglutaminase 3 and transglutaminase 6) identified roughly one in three (7 of 19, or 36.8%). Five of those seven were also positive for another gluten-related antibody.

What this means for you: a normal routine celiac panel does not fully rule out gluten-related autoimmunity. If your symptoms strongly suggest gluten sensitivity but standard tests are clear, these additional antibody targets are worth exploring with a clinician rather than assuming everything is fine.

A Preliminary Signal in Eczema

Outside gluten disease, the evidence is thin. In one study of atopic dermatitis (a common form of eczema), antibodies against transglutaminase 3 were higher in patients than in healthy people and tracked with rash severity. The dominant antibody involved there was a different class (IgE), not the IgG this test reports, so the relevance to IgG testing is uncertain, and the finding is early and not yet confirmed.

Why a Positive Result Is Not a Diagnosis

It is tempting to read any positive result as proof of skin disease, but the biology is messier. About 30% of people with celiac disease carry circulating transglutaminase 3 antibodies (measured in that research as the IgA class) without ever developing the rash, and skin deposits of these antibodies (also of the IgA class) have been found in roughly two-thirds (64.4%) of celiac patients who have no rash at all. This is not a clean good-number, bad-number marker. It is a signal of gluten-driven immune activity whose meaning depends on the antibody class, your symptoms, and your other tests. A positive result raises a question to investigate, not a conclusion.

Why One Reading Is Not Enough

This is a newer measurement without standardized cutoffs, which is exactly why a single number tells you little on its own. A baseline gives you a reference point, and tracking the trend over time shows whether a gluten-driven immune response is climbing or settling. You will have your own data to compare against as the science matures.

Related transglutaminase antibodies fall after gluten is removed from the diet and climb again during a gluten challenge, so serial testing can help gauge whether dietary changes are quieting the immune response. Keep in mind this pattern is best documented for the IgA class, and whether blood transglutaminase 3 IgG follows the same curve as reliably has been studied less. As a practical cadence (expert opinion rather than evidence-based guidance, since no monitoring interval has been established for this test): get a baseline, retest in 3 to 6 months if you change your diet, then at least once a year.

What an Unexpected Result Should Prompt

A positive or rising result is a starting point for a broader workup, not a standalone answer. Pair it with total IgA (to know whether IgA-based celiac tests are even valid for you), transglutaminase 2 IgA, and endomysial antibodies. If a rash is present, a dermatologist can take a skin biopsy for direct immunofluorescence, the most specific test for dermatitis herpetiformis.

Which specialist to involve depends on the pattern. Gut symptoms with positive celiac serology point toward a gastroenterologist and possibly a duodenal biopsy. A blistering rash points toward a dermatologist. If everything else is negative but symptoms persist, seronegative gluten sensitivity is worth discussing rather than dismissing.

When a Single Reading Can Fool You

• Recent gluten intake versus a gluten-free diet: because these antibodies respond to gluten, a result depends heavily on whether you have been eating it. Testing after months without gluten can produce a low reading even in someone who has the condition.
• IgA deficiency: if your body makes little IgA, the standard IgA-based celiac tests can read falsely low, which is one of the main reasons an IgG-based test is ordered in the first place.
• Antibody class confusion: this test measures the IgG class, while the diagnostic skin deposits in dermatitis herpetiformis are the IgA class. A normal IgG result does not rule out the IgA-driven skin disease.
• Assay variability: this is a research-grade test and methods differ between labs, so compare results from the same lab when tracking a trend over time.